Oric Pharmaceuticals President and CEO Sells Shares

TradingView
2025.12.18 00:20
portai
I'm PortAI, I can summarize articles.

Reporter NameChacko JacobRelationshipPRESIDENT AND CEO, 10% OwnerTypeSellAmount$302,368SEC FilingForm 4Jacob Chacko, President and CEO of Oric Pharmaceuticals and a 10% owner, sold 33,374 shares of common stock on December 16, 2025, at a weighted average price of $9.06 per share, totaling $302,368. This sale was to cover tax withholding obligations related to RSU vesting and was not a discretionary sale. Following this transaction, Chacko directly owns 581,711 shares of Oric Pharmaceuticals.SEC Filing: Oric Pharmaceuticals, Inc. [ ORIC ] - Form 4 - Dec. 17, 2025